GYRE
Gyre Therapeutics·NASDAQ
--
--(--)
--
--(--)
3.69 / 10
Netural
Fundamental measurement shows inadequate quality (3.7/10). Constructive metrics: Interest coverage ratio (EBIT / Interest expense) (%) and Profit-MV, though challenges appear in Total operating revenue (YoY growth rate %) and Operating revenue (YoY growth rate %). Final assessment: selective.
Analysis Checks(4/10)
Revenue-MV
Value-1.22
Score1/3
Weight12.52%
1M Return4.24%
Value-1.22
Score1/3
Weight12.52%
1M Return4.24%
Days sales outstanding
Value85.92
Score0/3
Weight-11.02%
1M Return-5.18%
Value85.92
Score0/3
Weight-11.02%
1M Return-5.18%
Net income-Revenue
Value0.06
Score3/3
Weight29.60%
1M Return9.29%
Value0.06
Score3/3
Weight29.60%
1M Return9.29%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-2.49%
1M Return-1.11%
Value15.48
Score2/3
Weight-2.49%
1M Return-1.11%
Asset-MV
Value-0.50
Score1/3
Weight18.20%
1M Return6.68%
Value-0.50
Score1/3
Weight18.20%
1M Return6.68%
Total operating revenue (YoY growth rate %)
Value1.94
Score1/3
Weight-1.82%
1M Return-0.79%
Value1.94
Score1/3
Weight-1.82%
1M Return-0.79%
Profit-MV
Value-0.39
Score2/3
Weight24.88%
1M Return8.45%
Value-0.39
Score2/3
Weight24.88%
1M Return8.45%
PB-ROE
Value3.34
Score0/3
Weight7.43%
1M Return2.72%
Value3.34
Score0/3
Weight7.43%
1M Return2.72%
Operating revenue (YoY growth rate %)
Value1.94
Score1/3
Weight-1.76%
1M Return-0.76%
Value1.94
Score1/3
Weight-1.76%
1M Return-0.76%
Cash-MV
Value-1.65
Score2/3
Weight24.46%
1M Return8.41%
Value-1.65
Score2/3
Weight24.46%
1M Return8.41%
Revenue-MV
Value-1.22
Score1/3
Weight12.52%
1M Return4.24%
Value-1.22
Score1/3
Weight12.52%
1M Return4.24%
Total operating revenue (YoY growth rate %)
Value1.94
Score1/3
Weight-1.82%
1M Return-0.79%
Value1.94
Score1/3
Weight-1.82%
1M Return-0.79%
Days sales outstanding
Value85.92
Score0/3
Weight-11.02%
1M Return-5.18%
Value85.92
Score0/3
Weight-11.02%
1M Return-5.18%
Profit-MV
Value-0.39
Score2/3
Weight24.88%
1M Return8.45%
Value-0.39
Score2/3
Weight24.88%
1M Return8.45%
Net income-Revenue
Value0.06
Score3/3
Weight29.60%
1M Return9.29%
Value0.06
Score3/3
Weight29.60%
1M Return9.29%
PB-ROE
Value3.34
Score0/3
Weight7.43%
1M Return2.72%
Value3.34
Score0/3
Weight7.43%
1M Return2.72%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-2.49%
1M Return-1.11%
Value15.48
Score2/3
Weight-2.49%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value1.94
Score1/3
Weight-1.76%
1M Return-0.76%
Value1.94
Score1/3
Weight-1.76%
1M Return-0.76%
Asset-MV
Value-0.50
Score1/3
Weight18.20%
1M Return6.68%
Value-0.50
Score1/3
Weight18.20%
1M Return6.68%
Cash-MV
Value-1.65
Score2/3
Weight24.46%
1M Return8.41%
Value-1.65
Score2/3
Weight24.46%
1M Return8.41%
Is GYRE fundamentally strong?
- GYRE scores 3.69/10 on fundamentals and holds a Fair valuation at present. Backed by its 5.72% ROE, 11.01% net margin, 114.13 P/E ratio, 5.52 P/B ratio, and 105.71% earnings growth, these metrics solidify its Netural investment rating.
